A Multicenter Phase II Study of Erlotinib and Sorafenib in Chemotherapy-Naïve Patients with Advanced Non–Small Cell Lung Cancer
暂无分享,去创建一个
E. Giovannetti | G. Peters | H. Groen | E. Smit | P. Postmus | F. Thunnissen | A. Dingemans | R. V. van Suylen | D. Heideman | J. Lind | R. Honeywell | O. Bekers